UBE2Q2P2

Across TCGA pan-cancer cohorts, UBE2Q2P2 RNA differs between tumor and matched normal tissue in 11 of 18 cancer types tested, making tumor–normal expression one of UBE2Q2P2’s most consistent transcriptional readouts.

The strongest signal is observed in thyroid carcinoma (THCA), where UBE2Q2P2 RNA is repressed in tumor relative to normal tissue. In most cancer types UBE2Q2P2 is over-expressed in tumor, although a few such as THCA and ESCA show the opposite, repressed pattern.

THCA, COAD, and LIHC are the cancer types where UBE2Q2P2 tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in UBE2Q2P2 RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
THCA	All	II,III,IV	−0.616	<.001	9	view →
COAD	All	II,III,IV	+0.436	.001	6	view →
LIHC	Female	All	+0.399	<.001	5	view →
LUSC	Male	All	+0.510	<.001	4	view →
BLCA	All	All	+0.631	.017	3	view →
CHOL	All	All	+1.222	.001	2	view →
UCEC	All	II,III,IV	+0.700	.042	2	view →
KIRP	All	IV	+0.662	.010	2	view →
ESCA	All	All	−0.586	.008	2	view →
KICH	Male	IV	+0.903	.010	1	view →
STAD	Female	III,IV	+0.625	.009	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 11 strongest of 11 lineages.

UBE2Q2P2–THCA

Open the THCA breakdown →